How much funding has Stilla Technologies raised?

Stilla Technologies has raised $66.5M in total funding, most recently a Series C round.

Who are Stilla Technologies's investors?

Stilla Technologies's investors include Illumina Ventures, Kurma Partners, Partech, LBO France, BNP Paribas Développement, Idinvest.

When was Stilla Technologies founded?

Stilla Technologies was founded in 2013.

Where is Stilla Technologies headquartered?

Stilla Technologies is headquartered in Villejuif, France.

What industry is Stilla Technologies in?

Stilla Technologies operates in Biotech.

How many employees does Stilla Technologies have?

Stilla Technologies has 11-50 employees.

Stilla Technologies

Acquired

Villejuif, France · Founded 2013 · $66.5M raised

Biotech

Headquarters: Villejuif
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: stillatechnologies.com
Total Funding: $66.5M
Last Round: $26.5M Series CFeb 2024
Rounds: 5

About

Stilla Technologies was a Paris-based biotechnology company founded in 2013 by Rémi Dangla and Clément Gay, specializing in multiplex digital PCR technology for life sciences research and clinical diagnostics. The company developed the naica Crystal Digital PCR system and the Nio product line, offering unique 7-color target detection capability that enabled high-resolution genetic analysis. Stilla's digital PCR platform served researchers and clinicians across oncology, infectious disease, genetic testing, and liquid biopsy applications. The company raised a €26.5 million Series C in 2024. Stilla was acquired by Bio-Rad Laboratories for up to $275 million in a deal announced in February 2025.

Summary

Stilla Technologies is a Biotech company based in Villejuif, France, founded in 2013. It has raised $66.5M in total across 5 rounds, most recently a $26.5M Series C round in Feb 2024. Investors include Illumina Ventures, Kurma Partners and Partech.